Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma

NCT00003356 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: rituximab

Sponsor

University of Rochester

Collaborators

[object Object]